More on MDGL
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $474.28 |
|
|||
| Open | $474.28 | ||||
| 52 Wk High | $18.24 | ||||
| 52 Wk Low | $6.60 | ||||
| Day High | $486.10 | ||||
| Day Low | $469.08 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 203,087 | ||||
- Madrigal Pharmaceuticals (MDGL) PT Lowered to $542 at BofA Securities
- Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
- Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026
- Madrigal Pharmaceuticals (MDGL) Reiterated at Market Outperform by Citizens
- Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH
- Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
- Madrigal to present Rezdiffra data at EASL 2026 conference
- Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk
- Madrigal Pharmaceuticals (MDGL) PT Raised to $709 at Truist Securities
- Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Entities mentioned with MDGL
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Goldman Sachs | View Related Stories »
- H.C. Wainwright | View Related Stories »
- S3 | View Related Stories »
- Show More...
